Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis

Journal of Proteome Research

Volumn 15, Issue 4, 2016, Pages 1126-1134

  Wang, Xiaoning ^a,b   Xie, Guoxiang ^c,d   Zhao, Aihua ^d   Zheng, Xiaojiao ^d   Huang, Fengjie ^d   Wang, Yixing ^b   Yao, Chun ^e   Jia, Wei ^c,d   Liu, Ping ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^e GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

bile acid; Child Pugh classification; cirrhosis; hepatitis B; serum

Indexed keywords

BILE ACID; GLYCOCHOLATE 3 GLUCURONIDE; GLYCOLITHOCHOLATE 3 SULFATE; GLYCOURSODEOXYCHOLATE; TAUROCHOLIC ACID; TAUROHYOCHOLATE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD SAMPLING; CHILD PUGH SCORE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; INVESTIGATIVE PROCEDURES; KIDNEY FUNCTION TEST; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE STUDY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINE LEVEL; BLOOD; CASE CONTROL STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; HEPATITIS B VIRUS; LIQUID CHROMATOGRAPHY; LIVER; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ADULT; BILE ACIDS AND SALTS; BIOMARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; KIDNEY FUNCTION TESTS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MASS SPECTROMETRY; MIDDLE AGED;

EID: 84963642776     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00217     Document Type: Article

References (42)

1. Schuppan, D.; Afdhal, N. H. Liver cirrhosis Lancet 2008, 371 (9615) 838-851
2. Murphy, S.; Xu, J.; Kochanek, K. Deaths: Final Data for 2010 National Vital Statistics Reports (Centers for Disease Control and Prevention) 2013, 61 (4) 1-118
3. Lok, A. S.; McMahon, B. J. Chronic hepatitis B: update of recommendations Hepatology 2004, 39 (3) 857-861
4. Llovet, J. M.; Burroughs, A.; Bruix, J. Hepatocellular carcinoma Lancet 2003, 362 (9399) 1907-1917
5. Child, C. G.; Turcotte, J. G. Surgery and portal hypertension Major Probl, Clin. Surg. 1964, 1, 1-85
6. Pugh, R. N.; Murray-Lyon, I. M.; Dawson, J. L.; Pietroni, M. C.; Williams, R. Transection of the oesophagus for bleeding oesophageal varices Br. J. Surg. 1973, 60 (8) 646-649
7. Malinchoc, M.; Kamath, P. S.; Gordon, F. D.; Peine, C. J.; Rank, J.; ter Borg, P. C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 2000, 31 (4) 864-871
8. Kamath, P. S.; Wiesner, R. H.; Malinchoc, M.; Kremers, W.; Therneau, T. M.; Kosberg, C. L.; DAmico, G.; Dickson, E. R.; Kim, W. R. A model to predict survival in patients with end-stage liver disease Hepatology 2001, 33 (2) 464-470
9. Kasper, D. L.; Braunwald, E.; Fauci, A. S.; Hauser, S. L.; Longo, D. L.; Jameson, J. L. Harrisons Principles of Internal Medicine, 16 th edition; McGraw-Hill Co.: New York, 2005.
10. Benedeto-Stojanov, D.; Nagorni, A.; Bjelakovic, G.; Stojanov, D.; Mladenovic, B.; Djenic, N. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding Vojnosanit. Pregl. 2009, 66 (9) 724-728
11. Testa, R.; Valente, U.; Risso, D.; Caglieris, S.; Giannini, E.; Fasoli, A.; Botta, F.; Dardano, G.; Lantieri, P. B.; Celle, G. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pughs score in liver cirrhosis? Eur. J. Gastroenterol. Hepatol. 1999, 11 (5) 559-563
12. Oellerich, M.; Burdelski, M.; Lautz, H. U.; Rodeck, B.; Duewel, J.; Schulz, M.; Schmidt, F. W.; Brodehl, J.; Pichlmayr, R. Assessment of pretransplant prognosis in patients with cirrhosis Transplantation 1991, 51 (4) 801-806
13. Garcia-Tsao, G.; Friedman, S.; Iredale, J.; Pinzani, M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis Hepatology 2010, 51 (4) 1445-1449
14. Christensen, E. Prognostic models in chronic liver disease: validity, usefulness and future role J. Hepatol. 1997, 26 (6) 1414-1424
15. Bajaj, J. S.; Ridlon, J. M.; Hylemon, P. B.; Thacker, L. R.; Heuman, D. M.; Smith, S.; Sikaroodi, M.; Gillevet, P. M. Linkage of gut microbiome with cognition in hepatic encephalopathy Am. J. Physiol Gastrointest Liver Physiol 2012, 302 (1) G168-G175
16. Bajaj, J. S.; Hylemon, P. B.; Ridlon, J. M.; Heuman, D. M.; Daita, K.; White, M. B.; Monteith, P.; Noble, N. A.; Sikaroodi, M.; Gillevet, P. M. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation Am. J. Physiol.: Gastrointest. Liver Physiol. 2012, 303 (6) G675-G685
17. Chen, Y.; Yang, F.; Lu, H.; Wang, B.; Lei, D.; Wang, Y.; Zhu, B.; Li, L. Characterization of fecal microbial communities in patients with liver cirrhosis Hepatology 2011, 54 (2) 562-572
18. Islam, K. B.; Fukiya, S.; Hagio, M.; Fujii, N.; Ishizuka, S.; Ooka, T.; Ogura, Y.; Hayashi, T.; Yokota, A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats Gastroenterology 2011, 141 (5) 1773-1781
19. Chen, T.; Xie, G.; Wang, X.; Fan, J.; Qiu, Y.; Zheng, X.; Qi, X.; Cao, Y.; Su, M.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma Mol. Cell. Proteomics 2011, 10 (7) M110 004945
20. Wang, X.; Xie, G.; Zhou, M.; Yu, H.; Lin, Y.; Du, G.; Luo, G.; Jia, W.; Liu, P. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients J. Proteome Res. 2012, 11 (7) 3838-3847
21. Yin, P.; Wan, D.; Zhao, C.; Chen, J.; Zhao, X.; Wang, W.; Lu, X.; Yang, S.; Gu, J.; Xu, G. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry Mol. Biosyst. 2009, 5 (8) 868-876
22. Vlahcevic, Z. R.; Buhac, I.; Bell, C. C., Jr.; Swell, L. Abnormal metabolism of secondary bile acids in patients with cirrhosis Gut 1970, 11 (5) 420-422
23. Kakiyama, G.; Pandak, W. M.; Gillevet, P. M.; Hylemon, P. B.; Heuman, D. M.; Daita, K.; Takei, H.; Muto, A.; Nittono, H.; Ridlon, J. M.; White, M. B.; Noble, N. A.; Monteith, P.; Fuchs, M.; Thacker, L. R.; Sikaroodi, M.; Bajaj, J. S. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis J. Hepatol. 2013, 58 (5) 949-955
24. Chinese Society of Hepatology, Chinese Medical Association and Chinese Society of Infectious Diseases Chinese Medical Association. Guideline on prevention and treatment of chronic hepatitis B in China (2005) Chin. Med. J. (Beijing, China, Engl. Ed.) 2007, 120 (24) 2159-2173
25. Bajaj, J. S.; Heuman, D. M.; Hylemon, P. B.; Sanyal, A. J.; Puri, P.; Sterling, R. K.; Luketic, V.; Stravitz, R. T.; Siddiqui, M. S.; Fuchs, M.; Thacker, L. R.; Wade, J. B.; Daita, K.; Sistrun, S.; White, M. B.; Noble, N. A.; Thorpe, C.; Kakiyama, G.; Pandak, W. M.; Sikaroodi, M.; Gillevet, P. M. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis Aliment. Pharmacol. Ther. 2014, 39 (10) 1113-11125
26. Xie, G.; Wang, Y.; Wang, X.; Zhao, A.; Chen, T.; Ni, Y.; Wong, L.; Zhang, H.; Zhang, J.; Liu, C.; Liu, P.; Jia, W. Profiling of Serum Bile Acids in a Healthy Chinese Population Using UPLC-MS/MS J. Proteome Res. 2015, 14 (2) 850-859
27. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS) J. Chemometr. 2002, 16 (3) 119-128
28. Mannes, G. A.; Thieme, C.; Stellaard, F.; Wang, T.; Sauerbruch, T.; Paumgartner, G. Prognostic significance of serum bile acids in cirrhosis Hepatology 1986, 6 (1) 50-53
29. Greco, A. V.; Mingrone, G. Serum bile acid concentrations in mild liver cirrhosis Clin. Chim. Acta 1993, 221 (1-2) 183-189
30. Jonsson, G.; Hedenborg, G.; Wisen, O.; Norman, A. Serum concentrations and excretion of bile acids in cirrhosis Scand. J. Clin. Lab. Invest. 1992, 52 (7) 599-605
31. Cravetto, C.; Molino, G.; Biondi, A. M.; Cavanna, A.; Avagnina, P.; Frediani, S. Evaluation of the diagnostic value of serum bile acid in the detection and functional assessment of liver diseases Ann. Clin. Biochem. 1985, 22 (Pt 6) 596-605
32. Qin, N.; Yang, F.; Li, A.; Prifti, E.; Chen, Y.; Shao, L.; Guo, J.; Le Chatelier, E.; Yao, J.; Wu, L.; Zhou, J.; Ni, S.; Liu, L.; Pons, N.; Batto, J. M.; Kennedy, S. P.; Leonard, P.; Yuan, C.; Ding, W.; Hu, X.; Zheng, B.; Qian, G.; Xu, W.; Ehrlich, S. D.; Zheng, S.; Li, L. Alterations of the human gut microbiome in liver cirrhosis Nature 2014, 513 (7516) 59-64
33. Swann, J. R.; Want, E. J.; Geier, F. M.; Spagou, K.; Wilson, I. D.; Sidaway, J. E.; Nicholson, J. K.; Holmes, E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments Proc. Natl. Acad. Sci. U. S. A. 2011, 1, 4523-4530
34. Sayin, S. I.; Wahlstrom, A.; Felin, J.; Jantti, S.; Marschall, H. U.; Bamberg, K.; Angelin, B.; Hyotylainen, T.; Oresic, M.; Backhed, F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist Cell Metab. 2013, 17 (2) 225-235
35. Claus, S. P.; Tsang, T. M.; Wang, Y.; Cloarec, O.; Skordi, E.; Martin, F. P.; Rezzi, S.; Ross, A.; Kochhar, S.; Holmes, E.; Nicholson, J. K. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes Mol. Syst. Biol. 2008, 4, 219
36. Paumgartner, G. Serum bile acids. Physiological determinants and results in liver disease J. Hepatol 1986, 2 (2) 291-298
37. Yang, J.; Zhao, X.; Liu, X.; Wang, C.; Gao, P.; Wang, J.; Li, L.; Gu, J.; Yang, S.; Xu, G. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B J. Proteome Res. 2006, 5 (3) 554-561
38. Yin, P.; Zhao, X.; Li, Q.; Wang, J.; Li, J.; Xu, G. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS) J. Proteome Res. 2006, 5 (9) 2135-2143
39. Thjodleifsson, B.; Barnes, S.; Chitranukroh, A.; Billing, B. H.; Sherlock, S. Assessment of the plasma disappearance of cholyll14C-glycine as a test of hepatocellular disease Gut 1977, 18 (9) 697-702
40. Hylemon, P. B.; Zhou, H. P.; Pandak, W. M.; Ren, S. L.; Gil, G.; Dent, P. Bile acids as regulatory molecules J. Lipid Res. 2009, 50 (8) 1509-1520
41. Holsti, P. Cirrhosis of the Liver induced in Rabbits by Gastric Instillation of 3-Monohydroxycholanic Acid Nature 1960, 186 (4720) 250
42. Yousef, I. M.; Tuchweber, B.; Vonk, R. J.; Massé, D.; Audet, M.; Roy, C. C. Lithocholate cholestasis-Sulfated glycolithocholate-induced intrahepatic cholestasis in rats Gastroenterology 1981, 80 (2) 233-241